000 | 01579 a2200409 4500 | ||
---|---|---|---|
005 | 20250516231301.0 | ||
264 | 0 | _c20150515 | |
008 | 201505s 0 0 eng d | ||
022 | _a1538-0688 | ||
024 | 7 |
_a10.1188/14.ONF.551-553 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHeld-Warmkessel, Jeanne | |
245 | 0 | 0 |
_aGemcitabine-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. _h[electronic resource] |
260 |
_bOncology nursing forum _cSep 2014 |
||
300 |
_a551-3 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 |
_aAdenocarcinoma _xcomplications |
650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use |
650 | 0 | 4 |
_aAntihypertensive Agents _xadministration & dosage |
650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadverse effects |
650 | 0 | 4 | _aBlood Component Transfusion |
650 | 0 | 4 |
_aDeoxycytidine _xadverse effects |
650 | 0 | 4 | _aDisease Management |
650 | 0 | 4 |
_aHemolytic-Uremic Syndrome _xchemically induced |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension _xcomplications |
650 | 0 | 4 |
_aKidney Failure, Chronic _xchemically induced |
650 | 0 | 4 | _aNursing Assessment |
650 | 0 | 4 |
_aPancreatic Neoplasms _xcomplications |
650 | 0 | 4 | _aPlasmapheresis |
650 | 0 | 4 |
_aPurpura, Thrombotic Thrombocytopenic _xchemically induced |
650 | 0 | 4 | _aRenal Dialysis |
650 | 0 | 4 | _aRituximab |
650 | 0 | 4 | _aGemcitabine |
773 | 0 |
_tOncology nursing forum _gvol. 41 _gno. 5 _gp. 551-3 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1188/14.ONF.551-553 _zAvailable from publisher's website |
999 |
_c24131769 _d24131769 |